Intangible Assets (Details) - Schedule of Intellectual Property Capitalized - USD ($) |
12 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Schedule of Intellectual Property Capitalized [Line Items] | ||
| Carrying amount, Balance | $ 4,804,791 | |
| Carrying amount, Balance | 4,142,060 | $ 4,804,791 |
| Cancer Stem Cell Technology [Member] | ||
| Schedule of Intellectual Property Capitalized [Line Items] | ||
| Carrying amount, Balance | 4,804,791 | 5,467,522 |
| Amortization expense | (662,731) | (662,731) |
| Carrying amount, Balance | $ 4,142,060 | $ 4,804,791 |
| X | ||||||||||
- Definition Amount of amortization expense for finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after accumulated amortization, of finite- and indefinite-lived intangible assets and capitalized cost for software to be sold, leased, or marketed. Excludes goodwill. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|